Bill to grant national importance tag to 6 pharma institutes tabled in Lok Sabha
New Delhi: Union Chemicals and Fertilisers Minister D V Sadananda Gowda on Monday introduced a bill in Lok Sabha that seeks to provide the national importance tag to six pharmaceutical education and research institutes in the country.
The National Institute of Pharmaceutical Education and Research (Amendment) Bill, 2021 provides for granting the status of nation importance to the six institutes in Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli.
The National Institute of Pharmaceutical Education and Research Act, 1998 (13 of 1998) was enacted to declare the National Institute of Pharmaceutical Education and Research at Mohali, Punjab to be an institute of national importance and to provide for its incorporation and matters connected therewith.
The Act was subsequently amended in 2007 to empower the central government to establish similar institutes in different parts of the country.
Thereafter, six new institutes in Ahmedabad, Guwahati, Hajipur, Hyderabad, Kolkata and Raebareli were established during 2007-08.
"A need is felt to bring clarity that the six institutes so established as well as any other similar institute to be established under the said Act shall be institutes of national importance," the statement of objects and reasons regarding the bill said.
In order to coordinate the activities of all such institutes, to ensure coordinated development of pharmaceutical education and research and maintenance of standards, etc., there is a need to establish a central body, to be called the Council, it noted.
Also, there is a need to rationalise the Board of Governors of each such institute and to widen the scope and number of courses run by such institutes, it said.
Read also: Include more Govt sites: CDSCO panel to Sanofi on clinical trial of pulmonary disease drug
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.